| Revised international prognostic scoring system for myelodysplastic syndromes PL Greenberg, H Tuechler, J Schanz, G Sanz, G Garcia-Manero, F Solé, ... Blood, The Journal of the American Society of Hematology 120 (12), 2454-2465, 2012 | 3294 | 2012 |
| Somatic mutations of calreticulin in myeloproliferative neoplasms T Klampfl, H Gisslinger, AS Harutyunyan, H Nivarthi, E Rumi, JD Milosevic, ... New England Journal of Medicine 369 (25), 2379-2390, 2013 | 2352 | 2013 |
| Clinical and biological implications of driver mutations in myelodysplastic syndromes E Papaemmanuil, M Gerstung, L Malcovati, S Tauro, G Gundem, ... Blood, The Journal of the American Society of Hematology 122 (22), 3616-3627, 2013 | 1981 | 2013 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1657* | 2020 |
| Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts E Papaemmanuil, M Cazzola, J Boultwood, L Malcovati, P Vyas, D Bowen, ... New England Journal of Medicine 365 (15), 1384-1395, 2011 | 1420 | 2011 |
| Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. L Malcovati, U Germing, A Kuendgen, MG Della Porta, C Pascutto, ... Journal of clinical oncology 25 (23), 3503-3510, 2007 | 1293 | 2007 |
| Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making L Malcovati, MGD Porta, C Pascutto, R Invernizzi, M Boni, E Travaglino, ... Journal of Clinical Oncology 23 (30), 7594-7603, 2005 | 1122 | 2005 |
| International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data DA Arber, A Orazi, RP Hasserjian, MJ Borowitz, KR Calvo, HM Kvasnicka, ... Blood, The Journal of the American Society of Hematology 140 (11), 1200-1228, 2022 | 1073 | 2022 |
| Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet L Malcovati, E Hellström-Lindberg, D Bowen, L Adès, J Cermak, ... Blood, The Journal of the American Society of Hematology 122 (17), 2943-2964, 2013 | 791 | 2013 |
| Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms L Malcovati, E Papaemmanuil, DT Bowen, J Boultwood, MG Della Porta, ... Blood, The Journal of the American Society of Hematology 118 (24), 6239-6246, 2011 | 579 | 2011 |
| SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts L Malcovati, M Karimi, E Papaemmanuil, I Ambaglio, M Jädersten, ... Blood, The Journal of the American Society of Hematology 126 (2), 233-241, 2015 | 473 | 2015 |
| Clinical significance of somatic mutation in unexplained blood cytopenia L Malcovati, A Gallì, E Travaglino, I Ambaglio, E Rizzo, E Molteni, C Elena, ... Blood, The Journal of the American Society of Hematology 129 (25), 3371-3378, 2017 | 455 | 2017 |
| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 453 | 2020 |
| Myelodysplastic syndromes—coping with ineffective hematopoiesis M Cazzola, L Malcovati N Engl J Med 352 (6), 536-538, 2005 | 452 | 2005 |
| The genetic basis of myelodysplasia and its clinical relevance M Cazzola, MG Della Porta, L Malcovati Blood, The Journal of the American Society of Hematology 122 (25), 4021-4034, 2013 | 442 | 2013 |
| Molecular international prognostic scoring system for myelodysplastic syndromes E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ... NEJM evidence 1 (7), EVIDoa2200008, 2022 | 387 | 2022 |
| Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS) L Malcovati, MG Della Porta, C Strupp, I Ambaglio, A Kuendgen, ... Haematologica 96 (10), 1433, 2011 | 382 | 2011 |
| Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome M Jadersten, L Malcovati, I Dybedal, M Giovanni Della Porta, R Invernizzi, ... Journal of Clinical Oncology 26 (21), 3607-3613, 2008 | 365 | 2008 |
| Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel T De Witte, D Bowen, M Robin, L Malcovati, D Niederwieser, ... Blood, The Journal of the American Society of Hematology 129 (13), 1753-1762, 2017 | 360 | 2017 |
| Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo PS Woll, U Kjällquist, O Chowdhury, H Doolittle, DC Wedge, S Thongjuea, ... Cancer cell 25 (6), 794-808, 2014 | 353 | 2014 |
